Abstract
Acute lymphoblastic leukemias (ALLs) are a group of hematologic neoplasias defined by cytomorphology, cytochemistry, and immunologic markers. The prognosis of ALL has much improved in the last 30 yr, especially in the age group between 2 and 10 yr where most patients can be cured by chemotherapy. The incidence of ALL is lower than for acute myelogenous leukemia (AML) (about 1–2 cases per 100,000 inhabitants in Western countries per year). In contrast to AML, a bimodal age peak is found in ALL: most cases occur in children and young adults followed by a second age peak beyond 60 yr. In the United States about 3000–4000 new cases of ALL are diagnosed each year.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Horowitz WM, Messerer D, Hoelzer D. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Am Int Med 1991; 115: 13–18.
Larson RA, Stock W, Hoelzer DF, Kantarjian H. Acute lymphoblastic leukemia in adults. Educational Brochure, American Society of Hematology, 1998.
Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605–615.
Thandla S, Aplan PD. Molecular biology of acute lymphocytic leukemia. Semin Oncol 1997; 24: 45–56.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Munker, R., Hiller, E., Paquette, R. (2000). Acute Lymphoblastic Leukemias. In: Modern Hematology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-203-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-59259-203-6_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5873-3
Online ISBN: 978-1-59259-203-6
eBook Packages: Springer Book Archive